Erdafitinib
Back to searchMolecule Structure
Scientific Name
Erdafitinib
Description of the Drug
Erdafitinib is a fibroblast growth factor receptor tyrosine kinase inhibitor used to treat locally advanced or metastatic urothelial carcinoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB12147
http://www.drugbank.ca/drugs/DB12147
Brand Name(s)
Balversa
Company Owner(s)
Janssen Biotech Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Fibroblast growth factor receptor | PROTEIN FAMILY | INHIBITOR | CHEMBL2095217 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL2583760 | |
| Human Metabolome Database | HMDB0251903 | |
| DrugBank | DB12147 | |
| PubChem | 67462786 | |
| PDBe | 5SF | |
| BindingDB | 50525939 | |
| DrugCentral | 5327 | |
| ChemicalBook | CB42725628 | |
| Guide to Pharmacology | 9039 | |
| rxnorm | BALVERSA | ERDAFITINIB |
| ZINC | ZINC000168520308 |
